Treatments
Overview
Clinics
Overview
UK-licensed, clinician prescribed
Next-day weekday delivery
Cancel any time, no consultation fee
Online weight loss treatments
Four licensed options, two pens and two tablets. One clinician decision, made with your history rather than a headline.
From £120 a month
The options
Weekly pen
Most weight lost
Tirzepatide · Once a week, same day
20.9%
average weight lost
SURMOUNT-1, 72 weeks
From £195 a month
Weekly pen
Semaglutide · Once a week, same day
14.9%
average weight lost
STEP 1, 68 weeks
From £139 a month
Daily tablet
No injections
Oral semaglutide · Once a day, before food
16.6%
average weight lost
OASIS 4, 64 weeks
From £125 a month
Daily tablet
No injections
Lowest price
Orforglipron · Once a day, any time
12.4%
average weight lost
ATTAIN-1, 72 week
From £120 a month
Side by side
↔ Swipe the table sideways
| MounjaroWeekly pen | WegovyWeekly pen | Wegovy tabletsDaily tablet | FoundayoDaily tablet | |
|---|---|---|---|---|
| Average weight lost in trials | 20.9% | 14.9% | 16.6% | 12.4% |
| Trial behind the figure | SURMOUNT-1 | STEP 1 | OASIS 4 | ATTAIN-1 |
| Trial length | 72 weeks | 68 weeks | 64 weeks | 72 week |
| Active ingredient | Tirzepatide | Semaglutide | Oral semaglutide | Orforglipron |
| How you take it | Weekly pen | Weekly pen | Daily tablet | Daily tablet |
| How often | Once a week, same day | Once a week, same day | Once a day, before food | Once a day, any time |
| Strengths available | 6 | 6 | 4 | 6 |
| Storage | Fridge until first use | Fridge until first use | No fridge | No fridge |
| Needles | Yes | Yes | None | None |
| From, a month | £195 | £139 | £125 | £120 |
| Tends to suit | You want the largest average result and are happy with a weekly injection. | You want the option with the longest track record behind it. | You want the results of semaglutide without an injection. | You want the simplest possible daily routine and the lowest starting price. |
Trial figures come from separate studies and are not head-to-head comparisons. Averages, not promises.
Which one suits you
“I want the biggest result”
You want the largest average result and are happy with a weekly injection.
Mounjaro →
“I do not want needles”
You want the results of semaglutide without an injection.
Wegovy tablets →
“I want the simplest daily routine”
You want the simplest possible daily routine and the lowest starting price.
Foundayo →
Choose a treatment to project
Your projection
Put in your details to see a personalised trajectory over 72 weeks, based on Mounjaro trial outcomes.
Your BMI
Included either way
Clinician review
Before anything is issued
UK pharmacy
GPhC registered, MHRA regulated
Tracked delivery
Next weekday, tracked
WhatsApp support
Seven days a week
Progress check-ins
As your dose steps up
Cancel any time
No lock-in, no consultation fee
Questions
In head-to-head terms, tirzepatide (Mounjaro) has produced the largest average weight loss of the licensed options in the UK: around 20.9% of body weight over 72 weeks in SURMOUNT-1, compared with about 14.9% for semaglutide 2.4mg (Wegovy) over 68 weeks in STEP 1. Trials are not directly comparable, and the best treatment for an individual is the one they tolerate and can keep taking, which is why a prescriber weighs medical history and side-effect risk rather than the headline figure alone.
There is no tablet form of tirzepatide licensed in the UK. Two oral GLP-1 options are available instead: oral semaglutide taken once a day, and orforglipron (Foundayo), also once a day. Average weight loss in their trials is lower than tirzepatide, so a tablet is usually chosen by people who want to avoid injections rather than by people chasing the largest possible result.
Wegovy tablets contain semaglutide, a peptide, so absorption is sensitive to food and drink: the tablet is taken on an empty stomach with a small sip of water, and food is delayed afterwards. Foundayo contains orforglipron, a small molecule, so it can be taken at any time of day with or without food. In their respective trials oral semaglutide 25mg produced about 16.6% average weight loss over 64 weeks and orforglipron about 12.4%.
Not quite, on the trial figures available. Weekly injections have produced the largest average reductions in body weight, with daily tablets somewhat behind. The gap matters less than adherence: a treatment taken consistently for a year outperforms a stronger one abandoned in month two, which is why the practical fit — needles, fridge space, routine — is part of the clinical decision.
Yes, switching is common and is done under prescriber supervision. Reasons include side effects, supply, cost, or wanting to move off injections. A switch usually restarts at a low dose of the new medicine rather than matching the old dose, because tolerance does not transfer between molecules, and the escalation is then stepped up again over several weeks.
Private prices typically run from around £120 to £375 a month depending on the medicine and the strength, with the lowest starting doses costing least and maintenance strengths costing most. A reputable service includes the prescriber review, the medicine, delivery and ongoing support in that figure, with no separate consultation fee.
In UK private practice, treatment is generally considered at a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, prediabetes, obstructive sleep apnoea or high cholesterol. Lower thresholds apply for people of South Asian, Chinese, Black African or African-Caribbean family background. Eligibility is confirmed by a prescriber reviewing full medical history, not by a calculator alone.
Appetite signalling returns to its previous state, and without a plan some weight is usually regained: the SURMOUNT-4 and STEP 4 withdrawal trials both showed this clearly. Ending treatment responsibly means tapering rather than stopping abruptly, with nutrition, resistance exercise and follow-up in place before the last dose so the change has somewhere to hold.
Prescription, clinician review and next-day weekday delivery to your door.
✓ Prescribed only after a clinician review
Quick self-check
Three quick questions. Takes under a minute.
Question 1 of 3
Your answers are confidential and reviewed by UK-registered clinicians.
WEIGHT LOSS
Established pen
Advanced pen
Daily oral — needle-free
Daily tablet — no timing rules
LONDON LOCATIONS
Marylebone · W1G · £250
Marylebone · W1H · £150
♢ UK-registered clinicians · Next-day weekday delivery